|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Net Income (Loss) From Continuing Operations | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Intangible asset amortization | |||||
| Noncash lease expense | |||||
| Financing fee and premium amortization | |||||
| Share-based compensation expense | |||||
| (Gain) loss from change in fair value of financial instruments | |||||
| Alight Holdings | |||||
| Total (Gain) loss from change in fair value of financial instruments | |||||
| (Gain) Loss from change in fair value of tax receivable agreement | |||||
| Alight Holdings | |||||
| Total (Gain) Loss from change in fair value of tax receivable agreement | |||||
| Release of unrecognized tax provision | |||||
| Deferred tax expense (benefit) | |||||
| Goodwill impairment | |||||
| Alight Holdings | |||||
| Total goodwill impairment | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Accounts payable and accrued liabilities | |||||
| Other assets and liabilities | |||||
| Cash provided by operating activities - continuing operations | |||||
| Cash provided by operating activities - discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Net proceeds from sale of business | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Capital expenditures | |||||
| Cash provided by (used in) investing activities - continuing operations | |||||
| Cash used in investing activities - discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Dividend payments | |||||
| Net increase (decrease) in fiduciary liabilities | |||||
| Borrowings from banks | |||||
| Repayments to banks | |||||
| Principal payments on finance lease obligations | |||||
| Payments on tax receivable agreements | |||||
| Tax payment for shares/units withheld in lieu of taxes | |||||
| Deferred and Contingent Consideration Payments | |||||
| Repurchase of shares | |||||
| Other financing activities | |||||
| Cash used for financing activities - continuing operations | |||||
| Cash provided by (used in) financing activities - discontinued operations | |||||
| Net Cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash - continuing operations | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash - discontinued operations | |||||
| Total effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Total cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Cash, cash equivalents and restricted cash balances from: | |||||
| Continuing operations - beginning of year | |||||
| Discontinued operations - beginning of year | |||||
| Less discontinued operations - end of period | |||||
| Less fiduciary cash transferred with sale of business | |||||
| Continuing operations - end of period | |||||
| Supplemental disclosures: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Fixed asset additions acquired through finance leases | |||||
| Right of use asset additions acquired through operating leases | |||||
| Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in fiduciary assets | |||||
Loading...